Roivant Sciences Ltd.
Roivant Sciences Ltd. (ROIV) Revenue
Annual & quarterly revenue history · segment & region breakdown
ROIV · revenue · updated Jun 8, 2026
Core revenue metrics
Trailing 12 monthsRoivant Sciences Ltd. trailing twelve-month (TTM) revenue is $0.01B, a decrease of 71.57% year-over-year from $0.01B in FY2026.
Revenue trend
2026 – 2020 · AnnualRevenue history
| Fiscal year end | Revenue | Change | Growth |
|---|---|---|---|
| 2026-03-31 | $0.01B | -$0.02B | -71.57% |
| 2025-03-31 | $0.03B | -$0.00B | -11.19% |
| 2024-03-31 | $0.03B | +$0.00B | +3.75% |
| 2023-03-31 | $0.03B | -$0.02B | -42.97% |
| 2022-03-31 | $0.06B | +$0.03B | +132.34% |
| 2021-03-31 | $0.02B | -$0.04B | -64.85% |
| 2020-03-31 | $0.07B | — | — |
Compare revenue vs peers
BiotechnologyCompare ROIV revenue against listed peers. Click any row to open that company's revenue tab.
Revenue breakdown
Segment & GeographyAbout Revenue & Reporting
Revenue (also called sales, net sales, or turnover) is the total income Roivant Sciences Ltd. receives from its business operations before deducting any costs or expenses. It is the top line of the income statement. Unlike net income or earnings, revenue does not account for operating costs, taxes, interest, or depreciation.
Roivant Sciences Ltd. reports revenue on a fiscal year ending Dec 31 basis under US GAAP, denominated in USD.
Data sourced from Roivant Sciences Ltd.'s 10-K and 10-Q SEC filings via Financial Modeling Prep.
Frequently asked questions
ROIV revenue · 4 questionsROIV's trailing twelve-month (TTM) revenue is $0.01B. That is a decrease of 71.57% year-over-year from $0.01B in FY2026.
▸ Source: FMP · Roivant Sciences Ltd. SEC filings · GAAP · Roivant Sciences Ltd. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026